Makito Kaneda

419 total citations
21 papers, 221 citations indexed

About

Makito Kaneda is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Makito Kaneda has authored 21 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 10 papers in Neurology and 6 papers in Epidemiology. Recurrent topics in Makito Kaneda's work include COVID-19 Clinical Research Studies (14 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and Long-Term Effects of COVID-19 (10 papers). Makito Kaneda is often cited by papers focused on COVID-19 Clinical Research Studies (14 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and Long-Term Effects of COVID-19 (10 papers). Makito Kaneda collaborates with scholars based in Japan. Makito Kaneda's co-authors include Hitoshi Kawasuji, Yoshihiro Yamamoto, Akitoshi Ueno, Yuki Miyajima, Yoshitomo Morinaga, Yasutaka Fukui, Ippei Sakamaki, Hideki Tani, Hiroshi Yamada and Yoshihiro Yoshida and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Makito Kaneda

17 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Makito Kaneda Japan	8	190	47	38	24	23	21	221
Akitoshi Ueno Japan	9	243 1.3×	50 1.1×	44 1.2×	27 1.1×	24 1.0×	20	284
Yuki Miyajima Japan	9	244 1.3×	50 1.1×	53 1.4×	41 1.7×	24 1.0×	22	314
Shuwei Zheng Singapore	7	186 1.0×	10 0.2×	55 1.4×	19 0.8×	53 2.3×	23	261
Audrey Giraud‐Gatineau France	9	126 0.7×	15 0.3×	53 1.4×	24 1.0×	26 1.1×	15	205
Xiao-Lei Xu China	7	250 1.3×	61 1.3×	39 1.0×	27 1.1×	15 0.7×	14	290
Hamda Khansaheb United Arab Emirates	7	147 0.8×	20 0.4×	43 1.1×	29 1.2×	16 0.7×	17	207
Enrico Richter Germany	6	115 0.6×	25 0.5×	23 0.6×	18 0.8×	23 1.0×	11	174
Marcos André Schörner Brazil	6	112 0.6×	5 0.1×	36 0.9×	27 1.1×	16 0.7×	15	182
Naomi Wilcox United States	5	223 1.2×	25 0.5×	35 0.9×	19 0.8×	37 1.6×	6	240
Isabelle Arm‐Vernez Switzerland	6	240 1.3×	28 0.6×	18 0.5×	15 0.6×	22 1.0×	8	259

Countries citing papers authored by Makito Kaneda

Since Specialization

Citations

This map shows the geographic impact of Makito Kaneda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makito Kaneda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makito Kaneda more than expected).

Fields of papers citing papers by Makito Kaneda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makito Kaneda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makito Kaneda. The network helps show where Makito Kaneda may publish in the future.

Co-authorship network of co-authors of Makito Kaneda

This figure shows the co-authorship network connecting the top 25 collaborators of Makito Kaneda. A scholar is included among the top collaborators of Makito Kaneda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makito Kaneda. Makito Kaneda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kawasuji, Hitoshi, Yasuhiro Tsuji, Takahiko Aoyama, et al.. (2025). High feasibility of salivary therapeutic drug monitoring in linezolid, but lower feasibility in tedizolid: a single-dose study in healthy subjects and a monocentric prospective exploratory study in patients who received linezolid. Journal of Antimicrobial Chemotherapy. 80(8). 2080–2091.

Kawasuji, Hitoshi, Yoshitomo Morinaga, Hideki Tani, et al.. (2024). Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4–5 vaccine and practical application of dried blood spots. Vaccine. 42(22). 126029–126029.

Nagaoka, Kentaro, Hitoshi Kawasuji, Makito Kaneda, et al.. (2024). Association between sore throat and early immune responses against COVID-19 before and after the emergence of the Omicron variant. Annals of Translational Medicine. 12(5). 87–87.

Kaneda, Makito, et al.. (2024). Time-dependent changes in cell population data obtained using Sysmex XN-series hematology analyzer in bacterial infections. Journal of Infection and Chemotherapy. 30(10). 983–988.

Kawasuji, Hitoshi, Yoshitomo Morinaga, Kentaro Nagaoka, et al.. (2024). High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection. Frontiers in Immunology. 15. 1377014–1377014. 2 indexed citations

Kawasuji, Hitoshi, Yoshitomo Morinaga, Hideki Tani, et al.. (2023). Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5. Microbiology Spectrum. 11(2). e0513122–e0513122. 12 indexed citations

Kaneda, Makito, Kentaro Nagaoka, Hitoshi Kawasuji, et al.. (2023). Pulmonary abscess caused by Cladosporium cladosporioides after receiving outpatient chemotherapy. Journal of Infection and Chemotherapy. 29(10). 993–996. 2 indexed citations

Nagaoka, Kentaro, Hitoshi Kawasuji, Makito Kaneda, et al.. (2023). Dominant CT Patterns and Immune Responses during the Early Infection Phases of Different SARS-CoV-2 Variants. Viruses. 15(6). 1304–1304. 1 indexed citations

Nagaoka, Kentaro, Hitoshi Kawasuji, Y Murai, et al.. (2023). Predictive values of immune indicators on respiratory failure in the early phase of COVID-19 due to Delta and precedent variants. Frontiers in Immunology. 14. 1197436–1197436. 3 indexed citations

10.

Kawasuji, Hitoshi, Makito Kaneda, Kentaro Nagaoka, et al.. (2023). High Incidence of Metastatic Infections in Panton-Valentine Leucocidin-Negative, Community-Acquired Methicillin-Resistant Staphylococcus aureus Bacteremia: An 11-Year Retrospective Study in Japan. Antibiotics. 12(10). 1516–1516. 1 indexed citations

11.

Nagaoka, Kentaro, Hitoshi Kawasuji, Makito Kaneda, et al.. (2023). Association of subpleural ground-glass opacities with respiratory failure and RNAemia in COVID-19. European Radiology. 33(7). 4713–4722. 5 indexed citations

12.

Kawasuji, Hitoshi, Kentaro Nagaoka, Yasuhiro Tsuji, et al.. (2023). Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis. Antibiotics. 12(4). 697–697. 24 indexed citations

13.

Nagaoka, Kentaro, Hitoshi Kawasuji, Makito Kaneda, et al.. (2022). Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure. Frontiers in Immunology. 13. 844304–844304. 14 indexed citations

14.

Kawasuji, Hitoshi, Yoshitomo Morinaga, Hideki Tani, et al.. (2022). Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population. Journal of Infection and Chemotherapy. 28(9). 1273–1278. 6 indexed citations

15.

Nagaoka, Kentaro, Hitoshi Kawasuji, Makito Kaneda, et al.. (2022). Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection. Viruses. 14(7). 1399–1399. 4 indexed citations

16.

Kawasuji, Hitoshi, Yoshitomo Morinaga, Hideki Tani, et al.. (2021). Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19. Scientific Reports. 11(1). 16535–16535. 8 indexed citations

17.

Fukui, Yasutaka, Hitoshi Kawasuji, Makito Kaneda, et al.. (2021). Investigation of nasopharyngeal viral load at discharge in patients with COVID-19. Journal of Infection and Chemotherapy. 27(7). 1122–1125. 1 indexed citations

18.

Kawasuji, Hitoshi, Yoshitomo Morinaga, Hideki Tani, et al.. (2021). SARS‐CoV‐2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID‐19. Journal of Medical Virology. 94(1). 147–153. 29 indexed citations

19.

Kawasuji, Hitoshi, Makito Kaneda, Akitoshi Ueno, et al.. (2021). A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test. International Journal of Infectious Diseases. 106. 33–35. 7 indexed citations

20.

Kawasuji, Hitoshi, Makito Kaneda, Akitoshi Ueno, et al.. (2020). Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients. PLoS ONE. 15(12). e0243597–e0243597. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact